Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms21228873 http://scihub22266oqcxt.onion/10.3390/ijms21228873 33238622!7700406!33238622     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33238622&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Int+J+Mol+Sci 2020 ; 21 (22): ? Nephropedia Template TP {{tp|p=33238622|t=2020. Combination Therapy to Treat Fungal Biofilm-Based Infections |pdf=|usr=}}{{33238622}} gab.com Text Combination Therapy to Treat Fungal Biofilm-Based Infections JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33238622 #FOAvip An increasing number of people is affected by fungal biofilm-based infections, which are resistant to the majority of currently-used antifungal drugs. Such infections are often caused by species from the genera Candida, Aspergillus or Cryptococcus. Only a few antifungal drugs, including echinocandins and liposomal formulations of amphotericin B, are available to treat such biofilm-based fungal infections. This review discusses combination therapy as a novel antibiofilm strategy. More specifically, in vitro methods to discover new antibiofilm combinations will be discussed. Furthermore, an overview of the main modes of action of promising antibiofilm combination treatments will be provided as this knowledge may facilitate the optimization of existing antibiofilm combinations or the development of new ones with a similar mode of action. Twit Text FOAVip Combination Therapy to Treat Fungal Biofilm-Based Infections ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33238622 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33238622 #FOAvip English Wikipedia <ref>{{Cite pmid|33238622}}</ref> Combination Therapy to Treat Fungal Biofilm-Based Infections #MMPMID33238622 Tits J; Cammue BPA; Thevissen K Int J Mol Sci 2020[Nov]; 21 (22): ? PMID33238622show ga An increasing number of people is affected by fungal biofilm-based infections, which are resistant to the majority of currently-used antifungal drugs. Such infections are often caused by species from the genera Candida, Aspergillus or Cryptococcus. Only a few antifungal drugs, including echinocandins and liposomal formulations of amphotericin B, are available to treat such biofilm-based fungal infections. This review discusses combination therapy as a novel antibiofilm strategy. More specifically, in vitro methods to discover new antibiofilm combinations will be discussed. Furthermore, an overview of the main modes of action of promising antibiofilm combination treatments will be provided as this knowledge may facilitate the optimization of existing antibiofilm combinations or the development of new ones with a similar mode of action. |Antifungal Agents/*therapeutic use[MESH] |Biofilms/*drug effects[MESH] |Candida/drug effects/pathogenicity[MESH] |Drug Resistance, Fungal/*drug effects[MESH] |Humans[MESH] |Microbial Sensitivity Tests[MESH]Combination Therapy to Treat Fungal Biofilm-Based Infections (epmc).pdf DeepDyve Pubget Overpricing